These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24516234)

  • 1. Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion.
    Erpicum P; Detry O; Weekers L; Bonvoisin C; Lechanteur C; Briquet A; Beguin Y; Krzesinski JM; Jouret F
    Nephrol Dial Transplant; 2014 Aug; 29(8):1487-93. PubMed ID: 24516234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury.
    Rowart P; Erpicum P; Detry O; Weekers L; Grégoire C; Lechanteur C; Briquet A; Beguin Y; Krzesinski JM; Jouret F
    J Immunol Res; 2015; 2015():602597. PubMed ID: 26258151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of endovenous versus arterial administration of mesenchymal stem cells for ischemia-reperfusion-induced renal dysfunction in rats.
    Zhuo W; Liao L; Fu Y; Xu T; Wu W; Yang S; Tan J
    Transplant Proc; 2013 Mar; 45(2):503-10. PubMed ID: 23498785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.
    Tögel F; Weiss K; Yang Y; Hu Z; Zhang P; Westenfelder C
    Am J Physiol Renal Physiol; 2007 May; 292(5):F1626-35. PubMed ID: 17213465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human umbilical cord mesenchymal stem cells on renal ischaemia-reperfusion injury in rats.
    Qiu Z; Zhou D; Sun D
    Int Braz J Urol; 2014; 40(4):553-61. PubMed ID: 25251960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives.
    Hu H; Zou C
    Curr Stem Cell Res Ther; 2017; 12(3):183-187. PubMed ID: 27781940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury.
    Cai J; Jiao X; Zhao S; Liang Y; Ning Y; Shi Y; Fang Y; Ding X; Yu X
    Cytotherapy; 2019 May; 21(5):535-545. PubMed ID: 30685215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
    Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
    Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury.
    Semedo P; Wang PM; Andreucci TH; Cenedeze MA; Teixeira VP; Reis MA; Pacheco-Silva A; Câmara NO
    Transplant Proc; 2007 Mar; 39(2):421-3. PubMed ID: 17362746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
    Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
    Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-modified Mesenchymal Stem Cell-based Therapy in Renal Ischemia- Reperfusion Injury.
    Xu H; Chen C; Hu L; Hou J
    Curr Gene Ther; 2017; 17(6):453-460. PubMed ID: 29446737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells: immunobiology and therapeutic potential in kidney disease.
    McTaggart SJ; Atkinson K
    Nephrology (Carlton); 2007 Feb; 12(1):44-52. PubMed ID: 17295660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of mesenchymal stem cells in acute kidney injury is affected by administration timing.
    Liu X; Cai J; Jiao X; Yu X; Ding X
    Acta Biochim Biophys Sin (Shanghai); 2017 Apr; 49(4):338-348. PubMed ID: 28338909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN-induced kinase 1 enhances the reparative effects of bone marrow mesenchymal stromal cells on mice with renal ischaemia/reperfusion-induced acute kidney injury.
    Lin C; Chen W; Han Y; Sun Y; Zhao X; Yue Y; Li B; Fan W; Zhang T; Xiao L
    Hum Cell; 2022 Nov; 35(6):1650-1670. PubMed ID: 35962179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice.
    Burks SR; Nguyen BA; Tebebi PA; Kim SJ; Bresler MN; Ziadloo A; Street JM; Yuen PS; Star RA; Frank JA
    Stem Cells; 2015 Apr; 33(4):1241-53. PubMed ID: 25640064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.
    Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L
    Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury.
    Brunswig-Spickenheier B; Boche J; Westenfelder C; Peimann F; Gruber AD; Jaquet K; Krause K; Zustin J; Zander AR; Lange C
    Stem Cells Dev; 2010 May; 19(5):719-29. PubMed ID: 20143956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale of mesenchymal stem cell therapy in kidney injury.
    Fleig SV; Humphreys BD
    Nephron Clin Pract; 2014; 127(1-4):75-80. PubMed ID: 25343826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale of mesenchymal stem cell therapy in kidney injury.
    Cantaluppi V; Biancone L; Quercia A; Deregibus MC; Segoloni G; Camussi G
    Am J Kidney Dis; 2013 Feb; 61(2):300-9. PubMed ID: 22938846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mesenchymal stem cells and darbepoetin improve ischemia-induced acute kidney injury outcomes.
    Altun B; Yilmaz R; Aki T; Akoglu H; Zeybek D; Piskinpasa S; Uckan D; Purali N; Korkusuz P; Turgan C
    Am J Nephrol; 2012; 35(6):531-9. PubMed ID: 22653289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.